집 » 모두 » 주식 예측 » Taysha Gene Therapies Inc. Common Stock 예측

Taysha Gene Therapies Inc. Common Stock 예측: 내일, 주, 월, 5년

업데이트됨: April 22 · 2026 at 07:03 UTC

From

▼ -3.71%Market Cap $1.79B · Technical analysis Bearish · Focus area Price + volatility

예측 요약

기간	예상 가격	과거	역사적인	통찰력
내일	$6.30 ▲ +1.33%	어제	$6.19 ▼ -0.56%	Tomorrow's Taysha Gene Therapies Inc. Common Stock (TSHA) setup is anchored to $6.22 and targets $6.30 (+1.33%). The near-term read is upside; watch $6.41 / $6.03 because daily realized volatility is about 6.84%.
Tomorrow's Taysha Gene Therapies Inc. Common Stock (TSHA) setup is anchored to $6.22 and targets $6.30 (+1.33%). The near-term read is upside; watch $6.41 / $6.03 because daily realized volatility is about 6.84%.
주	$6.48 ▲ +4.12%	지난주	$6.11 ▼ -1.73%	The 7-day Taysha Gene Therapies Inc. Common Stock model moves from $6.11 to $6.48 (+4.12%). It gives upside momentum context for this stock, so breaks around $6.41 / $6.03 matter more than a single tick.
The 7-day Taysha Gene Therapies Inc. Common Stock model moves from $6.11 to $6.48 (+4.12%). It gives upside momentum context for this stock, so breaks around $6.41 / $6.03 matter more than a single tick.
월	$6.77 ▲ +8.79%	전달	$5.99 ▼ -3.69%	The 1-month Taysha Gene Therapies Inc. Common Stock target is $6.77 (+8.79%), compared with the live reference near $6.22. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Taysha Gene Therapies Inc. Common Stock target is $6.77 (+8.79%), compared with the live reference near $6.22. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
년도	$7.20 ▲ +15.77%	작년	$5.81 ▼ -6.62%	The 1-year Taysha Gene Therapies Inc. Common Stock scenario points to $7.20 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Taysha Gene Therapies Inc. Common Stock scenario points to $7.20 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5년	$8.22 ▲ +32.14%	5년 전	$5.38 ▼ -13.50%	The 5-year Taysha Gene Therapies Inc. Common Stock view is $8.22 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Taysha Gene Therapies Inc. Common Stock view is $8.22 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

내일$6.30▲ +1.33%

어제$6.19▼ -0.56%

Tomorrow's Taysha Gene Therapies Inc. Common Stock (TSHA) setup is anchored to $6.22 and targets $6.30 (+1.33%). The near-term read is upside; watch $6.41 / $6.03 because daily realized volatility is about 6.84%.

주$6.48▲ +4.12%

지난주$6.11▼ -1.73%

The 7-day Taysha Gene Therapies Inc. Common Stock model moves from $6.11 to $6.48 (+4.12%). It gives upside momentum context for this stock, so breaks around $6.41 / $6.03 matter more than a single tick.

월$6.77▲ +8.79%

전달$5.99▼ -3.69%

The 1-month Taysha Gene Therapies Inc. Common Stock target is $6.77 (+8.79%), compared with the live reference near $6.22. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

년도$7.20▲ +15.77%

작년$5.81▼ -6.62%

The 1-year Taysha Gene Therapies Inc. Common Stock scenario points to $7.20 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5년$8.22▲ +32.14%

5년 전$5.38▼ -13.50%

The 5-year Taysha Gene Therapies Inc. Common Stock view is $8.22 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

가격 차트

역사적인예측강세약세

기술적 분석

Neutral

강세

중립적

약세

주요 지표

지시자	값	신호
Price	$6.22	Mid
Daily Change	-3.71%	Below
Volatility Cap	20.0%	Mid
Confidence	65%	Above
Data Source	nasdaq-screener	Mid

과거 데이터

Current$6.22

Daily Change-3.71%

Market Cap$1.79B

Sourcenasdaq-screener

Current	$6.22	Daily Change	-3.71%
Market Cap	$1.79B	Source	nasdaq-screener

지지 및 저항 수준

$6.03Support 1

$6.22현재의

$6.41Resistance 1

shield

Support and resistance are estimated from the trusted current price until deeper historical data is available.

가격 이정표

주요 수준 및 역사적 맥락

Current$6.22Live reference price

Used as the anchor for generated forecast calculations.

Next Month$6.77Model projection+8.79%

Directional scenario based on capped drift.

예측 정확도

우리 모델의 성능

65%

방향성

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

우리의 알고리즘은 최신 가격 조치, 변동성 체제 및 지표 신호를 사용하여 매주 재보정됩니다. 정확도는 기간에 따라 다릅니다. 단기적인 모멘텀이 장기 예측보다 더 안정적입니다.

Short term

65%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

투자 시나리오

오늘 TSHA에 $1,000를 투자한다면

Bullish Scenario

$6.53

+5.00% from current

목표가격$6.53

대본Upside momentum

개연성57%

Base Scenario

$6.77

+8.79%

목표가격$6.77

대본Capped drift

개연성65%

Bearish Scenario

$5.91

-5.00% from current

목표가격$5.91

대본Volatility drawdown

개연성35%

기초: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

예측 요인

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bullish · 69/100

24H drift+1.33%

7D drift+4.12%

30D drift+8.79%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-On Tentative · 66/100

1M outlook+8.79%

1Y outlook+15.77%

5Y outlook+32.14%

자주 묻는 질문

Q What is the Taysha Gene Therapies Inc. Common Stock (TSHA) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Taysha Gene Therapies Inc. Common Stock is projected near $6.30 versus the current reference around $6.22. That implies a modeled move of +1.33% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for TSHA?

The weekly Taysha Gene Therapies Inc. Common Stock model points to $6.48, which maps to an expected drift of +4.12% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the Taysha Gene Therapies Inc. Common Stock 1-month and 1-year targets?

The Taysha Gene Therapies Inc. Common Stock 1-month target is $6.77 (+8.79%), while the 1-year target is $7.20 (+15.77%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the Taysha Gene Therapies Inc. Common Stock 5-year scenario differ from short-term rows?

The Taysha Gene Therapies Inc. Common Stock long-horizon scenario sits near $8.22 with a modeled change of +32.14%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are TSHA support and resistance zones right now?

For Taysha Gene Therapies Inc. Common Stock, nearest resistance is around $6.03, while nearest support is around $6.41. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the Taysha Gene Therapies Inc. Common Stock market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.